Elevation Pharmaceuticals Receives $17,000,000 Series A Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fe54e9a4-c4d7-4f34-b60d-b07cdaa80c77&Preview=1
Date
9/26/2011
Company Name
Elevation Pharmaceuticals
Mailing Address
11455 El Camino Real San Diego, CA 92130
Company Description
Founded in 2008, Elevation Pharmaceuticals is developing a pipeline of improved aerosol drug products for COPD patients. Our founding team has a successful track record starting companies and building dedicated teams to develop new drug products that improve patients’ lives.
Website
http://www.elevationpharma.com
Transaction Type
Venture Equity
Transaction Amount
$17,000,000
Transaction Round
Series A
Proceeds Purposes
The funding will be used to pay for an ongoing mid-stage study of its experimental drug EP-101.
M&A Terms
Venture Investor
Canaan Partners
Venture Investor
TPG Capital
Venture Investor
Care Capital
Venture Investor
Mesa Verde Venture Partners